• Home
  • About us
    • Our history
    • Our team
  • Science
    • Neuroprotection
    • Immune Modulation
  • Pipeline
  • Partners
  • Newsroom

Our partners

  • Partners
  • Institutions funding aptaTargets
  • Investors

Partners

Stroke Unit - Vall d’Hebron (Barcelona)

Clinical Trials Unit & Neurology Department - La Princesa University Hospital (Madrid)

Neuroscience Department - German Trias i Pujol (Badalona)

Stroke Program - Institute of Biomedicine of Seville (IBiS) - Virgen del Rocío University Hospital (Sevilla)

Neurology Unit - Virgen Macarena University Hospital (Sevilla)

Aptus Biotech, aptamer technology

Neurovascular Research Unit, Universidad Complutense School of Medicine (Madrid)

IIBM - Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM, Madrid)

Francisco de Vitoria University (Madrid)

Instituto Cajal - CSIC (Madrid)

IRYCIS-Ramon y Cajal University Hospital (Madrid)

La Fe University Hospital (Valencia)

Institutions funding aptaTargets

EIT HEALTH

CDTI - Programa NEOTEC

Programa Retos-Colaboración - Programa Torres Quevedo

Comunidad de Madrid - MADRID (DOCTORADO INDUSTRIAL)

Investors

INVEREADY

CDTI - INNVIERTE Economía Sostenible

Esta empresa está capitalizada por Innvierte, iniciativa de inversión de CDTI, E.P.E.
This company is capitalized by Innvierte, an investment program of CDTI, E.P.E.

Aptatargets
Copyright © 2020 AptaTargets SL. All Right Reserved.
  • Home
  • Contact Us
  • Cookies policy
  • Legal notice
We use our own and third-party cookies to improve our services and show commercials related to your own preferences through the analysis of your browsing habits. Clicking Accept entails your acceptance in using them.
You can change this configuration or obtain additional information on legal warning.
ACCEPT